Sanofi Pasteur announced this week that Sklice, their ivermectin-based head lice treatment is now commercially available by prescription in the US.
The treatment is available in 0.5% solution from US pharmacies by prescription. FDA approval was granted for Sklice earlier this year following successful clinical trials.